Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Two-fraction High Dose Rate Brachytherapy as Monotherapy Delivered Three Hours Apart in Localized Prostate Cancer: A Pilot Study

NCT05665738 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05665738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05665738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Two-fraction High Dose Rate Brachytherapy as Monotherapy Delivered Three Hours Apart in Localized Prostate Cancer: A Pilot Study
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Recruiting
Start date
September 11, 2024
Completion date
February 28, 2029
Enrollment
17 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized prostate carcinoma, prostate adenocarcinoma